Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 9%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opi...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 46 1 87 80 88 00
Address:
Virdings allé 22, Uppsala, Sweden
Latest News on ORXOY
No data available.